Gilbert Smith
Child & Adolescent Psychiatry · Miami, FLNPI 1508235359
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 163 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,117 and has fallen 53.9% since, to $515 in 2024.
Across 163 payments — averaging $25.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$924
- Tris Pharma Inc$681
- Sunovion Pharmaceuticals Inc.$663
- Otsuka America Pharmaceutical, Inc.$481
- Corium, LLC$375
- Takeda Pharmaceuticals U.S.A., Inc.$316
- plus $753 from 10 others
What the payments were for
- Food & beverage$4,194100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 32 | $924 |
| Tris Pharma Inc | 28 | $681 |
| Sunovion Pharmaceuticals Inc. | 23 | $663 |
| Otsuka America Pharmaceutical, Inc. | 23 | $481 |
| Corium, LLC | 14 | $375 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $316 |
| AstraZeneca | 1 | $124 |
| Vertical Pharmaceuticals, LLC | 5 | $99 |
| Shire North American Group Inc | 5 | $96 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $90 |
| Lundbeck LLC | 5 | $87 |
| Supernus Pharmaceuticals, Inc. | 5 | $85 |
| Alkermes, Inc. | 1 | $76 |
| AbbVie | 2 | $58 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Adlon Therapeutics L.p. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Jornay PM 20mg capsules (Bottle of 100)$277
- Dyanavel XR$191
- LATUDA$125
- FARXIGA$124
- Azstarys$122
- REXULTI$120
How this compares
$4,194 in reported general payments places this provider in the 85th percentile of 206 child & adolescent psychiatry providers in Florida.
See all child & adolescent psychiatry providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonazepam | 12 | $214 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Miami
- Sean HoranMiami$17K
- Americo PadillaMiami$11K
- Jose AlvarezMiami$6K
- Nicole RedondoMiami$4K
- Jonathan ParkerMiami$4K
- Janeris LoredoMiami$3K
- Jerome SiegmeisterMiami$3K
- Mauricio RodriguezMiami$3K
- Yasin BezMiami$2K
- Craig KuninsGulfport$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.